{"id":"cd1579-5","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Skin irritation"},{"rate":"5-10%","effect":"Dryness"},{"rate":"5-10%","effect":"Redness"}]},"_chembl":{"chemblId":"CHEMBL735","moleculeType":"Small molecule","molecularWeight":"333.32"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"CD1579 5% works by binding to retinoic acid receptors, which are involved in regulating cell growth and differentiation. This leads to an increase in cell turnover and a decrease in the appearance of fine lines and wrinkles.","oneSentence":"CD1579 5% is a topical retinoid that modulates cell growth and differentiation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:50:07.647Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris"},{"name":"Photoaging"}]},"trialDetails":[{"nctId":"NCT03034460","phase":"PHASE2","title":"Efficacy and Safety of CD5024 1% in Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-04-25","conditions":"Acne","enrollment":70},{"nctId":"NCT01688531","phase":"PHASE1","title":"A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2012-08","conditions":"Acne","enrollment":38},{"nctId":"NCT02073461","phase":"PHASE2","title":"Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2014-03","conditions":"Acne Vulgaris","enrollment":236}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Benzoyl Peroxide 5%"],"phase":"phase_2","status":"active","brandName":"CD1579 5%","genericName":"CD1579 5%","companyName":"Galderma R&D","companyId":"galderma-r-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CD1579 5% is a topical retinoid that modulates cell growth and differentiation. Used for Acne vulgaris, Photoaging.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}